CAPURSO, GABRIELE
 Distribuzione geografica
Continente #
EU - Europa 886
NA - Nord America 728
AS - Asia 557
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.180
Nazione #
US - Stati Uniti d'America 724
SE - Svezia 330
SG - Singapore 290
RU - Federazione Russa 250
CN - Cina 213
IT - Italia 180
FI - Finlandia 29
IE - Irlanda 24
DE - Germania 21
FR - Francia 16
HK - Hong Kong 15
IN - India 13
GB - Regno Unito 11
TW - Taiwan 8
BR - Brasile 6
IR - Iran 6
CA - Canada 4
CZ - Repubblica Ceca 4
TR - Turchia 4
UA - Ucraina 4
PT - Portogallo 3
AT - Austria 2
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
IQ - Iraq 2
JP - Giappone 2
PL - Polonia 2
EU - Europa 1
GR - Grecia 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
NL - Olanda 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 2.180
Città #
Singapore 178
Shanghai 126
Ashburn 102
Moscow 88
Lawrence 85
Princeton 85
Dallas 66
Boardman 65
New York 62
Milan 49
Helsinki 26
Dublin 24
Washington 22
Majano 18
Seattle 15
Rome 14
Hong Kong 13
London 10
Los Angeles 10
Pune 10
Beijing 9
Vaprio d'Adda 8
Columbus 7
Jiaxing 7
Chang-hua 6
Guangzhou 6
Mountain View 6
Santa Clara 6
Verona 6
Carlsbad 5
Clifton 5
Munich 5
Ancona 4
Bergamo 4
Bologna 4
Florence 4
Shenzhen 4
St Petersburg 4
Thousand Oaks 4
Genoa 3
Kyiv 3
Lappeenranta 3
Oakville 3
Paris 3
Strasbourg 3
Villa Guardia 3
Acireale 2
Austin 2
Baghdad 2
Barcelona 2
Bari 2
Berlin 2
Bern 2
Brussels 2
Cagliari 2
Cambridge 2
Canberra 2
Civitavecchia 2
Cordenons 2
Fort Worth 2
Kish 2
Krakow 2
Lanciano 2
Landshut 2
Lecco 2
Miami 2
New Delhi 2
Nizhniy Novgorod 2
Pisa 2
Porto 2
Redwood City 2
Rimini 2
Rio de Janeiro 2
Romainville 2
Saint-Denis 2
San Francisco 2
San Maurizio Canavese 2
Stuttgart 2
Taipei 2
Teramo 2
Tulln 2
Turin 2
Zhengzhou 2
Arezzo 1
Borås 1
Brescia 1
Brno 1
Bucharest 1
Buffalo 1
Campodolcino 1
Cassano d'Adda 1
Cheyenne 1
Chiaravalle 1
Chicago 1
Germantown 1
Hachenburg 1
Houston 1
Kolkata 1
Las Vegas 1
Liberty Lake 1
Totale 1.284
Nome #
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 55
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 32
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 26
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 25
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 25
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 25
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 24
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 24
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 23
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 23
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 23
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 23
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 22
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 22
European evidence-based guidelines on pancreatic cystic neoplasms 22
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 22
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 22
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 21
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 21
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 20
Urgent manifestations of immunoglobulin G4-related disease 20
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 19
Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy: A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread 19
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 19
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 19
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 19
Update on gastroenteropancreatic neuroendocrine tumors 18
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 18
Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? 18
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 17
The impact of nutritional status on pancreatic cancer therapy 17
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 17
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 17
Consensus guidelines on severe acute pancreatitis 17
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 17
Genome-wide association study identifies an early onset pancreatic cancer risk locus 17
Artificial intelligence in EUS for autoimmune pancreatitis: Bias and real life 17
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 16
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 16
Slow-pull compared to suction technique for EUS-guided sampling of pancreatic solid lesions: a meta-analysis of randomized controlled trials 16
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis 16
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 16
Risk factors for the occurrence of ampullary tumors: A case-control study 15
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 15
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 15
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 15
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 15
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 15
How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review 15
Endosonography-guided radiofrequency ablation in pancreatic diseases: Time to fill the gap between evidence and enthusiasm 15
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 15
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 14
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 14
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 14
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 14
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 14
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 14
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 14
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 14
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 14
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 14
Diagnostic performance of Endoscopic Ultrasound Through-The-Needle microforceps Biopsy (EUS-TTNB) of pancreatic cystic lesions: a systematic review with meta-analysis 14
MYC up-regulation confers resistance to everolimus and establishes vulnerability to cyclin dependent kinase inhibitors in pancreatic neuroendocrine neoplasms cells 14
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: An international multicentre study 14
Machine learning for the prediction of post-ERCP Pancreatitis risk: A proof-of-concept study 14
Genetic and non-genetic risk factors for early-onset pancreatic cancer 13
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 13
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 13
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 13
Correction to: Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature? (Clinical and Translational Gastroenterology, (2018), 9, 6, (158), 10.1038/s41424-018-0026-3) 13
Pancreatic cyst surveillance imposes low psychological burden 13
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 13
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 13
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 13
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 13
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 12
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma 12
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 12
Chronic Asymptomatic Pancreatic Hyperenzymemia (CAPH): Meta-analysis of pancreatic findings at second-level imaging 12
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients with Autoimmune Pancreatitis: Systematic Review and Meta-analysis 11
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 11
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 11
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 11
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 11
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 11
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. 11
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study 11
SECONDARY CANCERS IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (IPMN): PRELIMINARY RESULTS OF A PROSPECTIVE MULTICENTRE ITALIAN STUDY 11
Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study 11
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis 11
Pancreatic cystic neoplasms in 2018: The final cut 11
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 11
Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports 10
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 10
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 10
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 10
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 10
The use of ace inhibitors influences the risk of progression of BD-IPMNs under follow-up 10
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 10
RISK FACTORS FOR INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (IPMN) OF THE PANCREAS: PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN MULTICENTRE CASE-CONTROL STUDY 10
Totale 1.617
Categoria #
all - tutte 43.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 30 0 0 0 0 0
2020/202145 0 0 0 0 26 15 3 0 1 0 0 0
2021/202269 0 0 1 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/2025738 512 138 88 0 0 0 0 0 0 0 0 0
Totale 2.592